KPV
C-terminal tripeptide fragment of alpha-MSH discussed in immune and barrier research.
Overview
Sometimes stacked with BPC-157 in community templates — keep expectations modest.
What it is
Lysine-proline-valine tripeptide.
Mechanism (high level)
Preclinical work explores anti-inflammatory and epithelial barrier themes.
Quick facts
- Dosage
- Research discussion — no standard human dose
- Route
- Oral or SubQ in discussion
- Cycle
- Template-dependent
- Storage
- Lyophilized cool, dry
Research indications
- GI inflammation models (preclinical)
Research protocols (education)
Education-first logging template
Use PepTok to track adherence and notes; any protocol must be directed by a qualified clinician.
Interactions
Often avoided with
- Immunosuppressants without specialist input
Often combined with
- Baseline nutrition
Peptides discussed online are not substitutes for diagnosis or prescriptions.
Side effects & safety
- Limited human data — discuss risks with a clinician.
Regulatory notes
- Research-grade in consumer channels.
FAQ
Is this a prescription?
PepTok does not provide prescriptions; it is for logging and education.
Related in catalog
Track in app
Save favorites, compare protocols, and track over time
PepTok gives you structure: stacks, reminders, notes, and progress snapshots in one place.
Educational content only. This material is not medical advice. Verify legality, sourcing, and dosing with a qualified professional.